Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
Presbyopia, the age-related loss of near vision, could soon be treated successfully
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
Subscribe To Our Newsletter & Stay Updated
